Table 1.
Demographic and clinical characteristics, N = 18
| Variable | Participants n (%) |
|---|---|
| Gender | |
| Male | 14 (77.8) |
| Ethnicity | |
| White | 7 (38.9) |
| Hispanic | 2 (11.1) |
| African American | 7 (38.9) |
| Other | 2 (11.1) |
| Number of Medications |
M (SD) 6.8 |
| Comorbidities | n (%) |
| Hypertension | 14 (77.8) |
| Hyperlipidemia | 7 (38.9) |
| Diabetes Mellitus | 3 (16.7) |
| Congestive Heart Failure | 6 (33.3) |
| Depression | 4 (22.2) |
| Coronary Artery Disease | 5 (27.8) |
| Chronic Obstructive Pulmonary | 5 (27.8) |
| Disease | |
| n (%)a | |
| Indication for Warfarin Therapy | 5 (27.8) |
| Atrial fibrillation | 4 (22.2) |
| Pulmonary embolism | 4 (22.2) |
| Deep vein thrombosis | 3 (16.7) |
| Heart valve | 2 (11.1) |
| Mural thrombus | |
aOne patient had more than one indication